Delivery Order SPE2DB20D2001-SPE2DB25FPMJY
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,595.50, is for the delivery of 4,567,760,063 capsules of Tamsulosin HCL 0.4 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. This contract is not associated with a set-aside designation, indicating open competition....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,376.02, is for the delivery of 4,566,770 units of Tamsulosin HCL 0.4 mg Capsules. The contract has an ultimate completion date of December 20, 2024 and is a Firm Fixed Price type contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,999.92, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules to support federal healthcare programs. The contract has a firm fixed price pricing type and a period of performance through January 17, 2024. There is no set-aside designation for this award. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,990.26, is for the delivery of 4,567,985,363 units of Tamsulosin HCl 0.4 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.86 Firm Fixed Price contract is for the supply of 4,567,152,479 units of Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of February 5, 2025 and was awarded on February 4, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,092.74, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of January 21, 2025. This contract is a task order under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,721,093 units of Tamsulosin HCL 0.4 mg capsules, with a ceiling value of $2,585.21. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,732.04, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of March 6, 2025. This is a firm fixed-price contract and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,156.72, is for the delivery of 4,567,908,356 units of the prescription drug Tamsulosin HCL 0.4 mg capsules. The contract is a firm-fixed price delivery order that runs through April 15, 2025. This contract award is not associated with a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,635,162 units of Tamsulosin HCl 0.4 mg capsules. The contract has a firm fixed price of $2,642.23 and a completion date of February 13, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...